We used structure-activity relationships to identify new compounds that inhibit the SARS-CoV-2 main protease. Four rules for designing effective inhibitors have been proposed, guiding medicinal chemists in the search for potential treatments. A potential lead compound, GB111-NH2, has been identified based on these rules.
Comments